HLI is currently developing collaborations with companies in the genomic and stem cell arenas, with large hospital systems and clinics that will utilize our services and with pharmaceutical companies that can foster discovery and develop new therapeutics.
Some of the agreements that HLI has announced to date:
HLI has entered into a collaboration with Metabolon Inc., the worldâ€™s leader in the field of metabolomics. Metabolon has developed proprietary technology to quickly identify and measure the bodyâ€™s biochemicals and will provide such biochemical profiling services to HLI. In the initial term of the agreement Metabolon will carry out small molecule analysis of 10,000 subjects and collaborate with HLI to map changes in the small molecules to end points of disease and gene mutations. – less–ZoomInfo